ArticleFrontiers in oncology2022

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients.

Hiu Ting Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.